Safety of percutaneous transhepatic biliary stenting in patients with obstructive jaundice by Khan, Rafeah et al.
eCommons@AKU
Department of Radiology Medical College, Pakistan
January 2019
Safety of percutaneous transhepatic biliary stenting
in patients with obstructive jaundice
Rafeah Khan
Zainab Hussain
Aga Khan University, zainab.hussain@aku.edu
Vaqar Bari
Aga Khan University, vaqar.bari@aku.edu
Azeikah Ben Fiaz
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol
Recommended Citation
Khan, R., Hussain, Z., Bari, V., Fiaz, A. (2019). Safety of percutaneous transhepatic biliary stenting in patients with obstructive
jaundice. Journal of the College of Physicians and Surgeons Pakistan, 29(1), 24-28.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol/328
70 Journal of the College of Physicians and Surgeons Pakistan 2019, Vol. 29 (1): 70-72
INTRODUCTION
Ross procedure (RP) is therapeutic for patients with a
diseased aortic valve with particular benefits in pediatric
population due to hemodynamic advantages, adaptation
to growth, and freedom from anti-coagulation.1 In a
systematic review of reports between 1967 and 2013 by
Berdajs and colleagues, the overall survival was >90%
over 10 years after Ross procedure.2 In the same study,
freedom from overall re-intervention over 10 years was
superior to 93% in comparison to 10% re-operation rate
with mechanical prosthesis and 30% with bioprosthesis.2
First described by Donald Ross in 1967,3 RP has under-
gone technical evolution to prevent the late complications
associated with it. Initially, the modality used was sub-
coronary technique which includes implantation of free
dissected leaflets of pulmonary root in a sub-coronary
position in the aortic root.3 However, because of
technical complexity as well as failure due to structural
valve deterioration, the procedure did not gain wide
acceptance.4
In late 1980s, invention of free-standing root replace-
ment modality, which includes aortic root replacement
with a pulmonary root autograft, brought a wider approval
of the Ross procedure due to its relative less demanding
nature.4 Owing to the higher re-operation rate due to late
aortic root dilation and rising aortic regurgitation even
with this technique,5 a number of techniques have
evolved to support the autograft. These manipulations
mainly are composed of stabilisation of autograft
annulus and autograftsinotubular junction with Teflon
patch or pericardium to avoid dilatation of these sites.6
Other modifications that have been proposed in
literature are wrapping the entire autograft externally
with a tubular polyester graft to prevent aneurysmal
enlargement of neo-aortic root or by the use of Dacron
interposition graft.7
The technique of insertion of pulmonary autograft in
Ross procedure plays a key role in determining the need
of autograft re-operation which is the principal limitation
of this procedure. These techniques aim to stabilise the
aortic root geometry and avoid pulmonary autograft
dilatation that leads to subsequent development of aortic
regurgitation (AR), a common means of late RP failure.
Limited literature available regarding RP in local
population merits the need of comprehensive review to
assess operative and postoperative course in this
population.
The objective of this report was to describe the outcome
of two variations of Ross procedure.
METHODOLOGY
This case series was conducted at a tertiary care hospital,
after receiving approval from Ethics Review Committee.
The patient population reported includes all eight
patients who underwent the Ross procedure during the
10 years duration between January 2007 and December
2016. All preoperative, surgical, and post-operative data
were obtained from medical records of the patients.
All procedures were carried out by a single surgeon.
Intraoperative transesophageal two-dimensional and
color-flow Doppler echocardiography was performed to
assess pulmonary valve competence and diameters
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of pulmonary root's annulus and sinuses. After
heparanization, standard cardiopulmonary bypass was
used. Blood cardioplegia (4°C) was given initially
through aortic root and then via coronary ostia for
myocardial protection. Transverse aortotomy was
performed in all patients. In all cases, pulmonary
autograft was used for aortic root replacements with
coronary reimplantation. Continuous running suture
technique was employed in all the patients. There were
minimal differences between the aortic annulus and the
autograft. Six patients received free standing total root
replacement while two patients with mixed aortic
stenosis and aortic regurgitation had Dacron tube
(Vascutek, Terumo Cardiovascular Systems Inc, Ann
Arbor, MI) interposed between the autograft and the
ascending aorta to stabilise the autograft and prevent
aneurysmal enlargement of neo-aortic root. Contegra
bio prosthesis conduit was used in four patients and
manually constructed composite valved conduit
including a combination of PTFE (polytetrafluoroethelene)
membrane and bovine pericardium in other four
patients. Aortic cross clamp was removed after
reconstruction of RVOT. At the end of procedure,
competence of pulmonary autograft and RVOT conduit
was confirmed by transesophageal echocardiography.
RESULTS
Demographic characteristics and dominant hemo-
dynamic conditions are shown in Table I. The median
age of patients was 14 years. Three patients had
received previous cardiac surgeries. Two patients had
undergone ventricular septal defect (VSD) closure in the
past. One patient underwent balloon aortic valvuloplasty.
Another patient underwent aortic valve repair previously
in childhood. Four patients had bicuspid aortic valves.
Technical varieties of Ross procedure
Table I: Demographics of the series.
Patient No. Age (years) Gender Dominant  Previous NYHA Valve 
hemodynamic intervention Pathology
condition
1 14 Female AS/AR None Class 3 Endocarditis
2 11 Male AS/AR Balloon aortic Class 1 Bicuspid 
valvuloplasty aortic valve
3 27 Female AS/AR None Class 1 Bicuspid 
aortic valve
4 14 Male AR VSD closure Class 2 None
5 11 Female AR Aortic valve Class 1 None
repair VSD closure
6 13 Male AR None Class 1 Bicuspid 
aortic valve
7 19 Male AS None Class 1 Bicuspid 
aortic valve
8 16 Male AR None Class 2 None
AS = Aortic stenosis, AR = Aortic regurgitation, VSD = Ventricular septal defect.
Table II: Intraoperative data and postoperative course.
Patient No. CPB time (min) Aortic cross  Operative RVOT RVOT Concomitant ICU stay Acute Neo-aorta Follow-up 
clamp time (min) technique conduit used conduct sizes procedures (days) complications deterioration duration
1 195 170 Modified total root Contegra Bior 22 PDA ligation 2 None Mild AR 3
replacement with osthesis
Dacron interposition
2 240 180 Modified total root PTFE membrance 20 None 3 Perioperative No 12
replacement with and bovine pericardial
Dacron interposition tueb graft
3 205 165 Free standing PTFEE membrane 22 None 2 None Trace AR 3
root replacement and bovine pericardial
tube graft
4 180 160 Free standing Contegrabioprosthesis 20 None 1 None Mild AR 1
root replacement
5 216 170 Free standing root Contegrabioprosthesis 22 None 1 None No 72
replacement
6 200 155 Free standing root Contegrabioprosthesis 22 None 1 Generalised Severe AR 24
replacement tonic clonic
seizures
7 180 150 Free standing root PTFE membrance 20 None 2 Seizures Trace AR 36
replacement and bovine pericardial
tube graft
8 190 145 Free standing root PTFE membrance 22 None 2 Sepsis Trace AR 3
replacement and bovine pericardial
tube graft
CPB = Cardiopulmonary bypass,   RVOT = Right ventricular outflow tract,   AR = Aortic regurgitation.
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Details of intraoperative and postoperative course are
listed in Table II. Median CBP and cross-clamp time
were 198 min and 162 min, respectively. One patient
received PDA ligation concomitantly. No mortality
occurred in this set of patients. Complications included
two post-operative seizures, and perioperative bleeding
in another. Median ICU stay in this series was 2 days.
In this series, none of the patients underwent autograft
replacement in the follow-up duration. Bacterial valve
endocarditis or valve related thromboembolism was also
not seen.
Echocardiography showed severe neo-aortic valve
regurgitation in one patient on last follow-up. Three
patients demonstrated trace AR and another two had
mild AR on last follow-up visit. Trace pulmonary
regurgitation was seen in two patients while mild RVOT
obstruction with peak pulmonary gradients of 20 mm of
mercury and 22 mm of mercury noticed in two patients.
They were all asymptomatic with normal right ventricular
function. None of the patients underwent re-operation for
RVOT conduit failure in the follow-up duration.
DISCUSSION
Ross procedure in itself is a technically demanding
procedure with greater cross-clamping time as
compared to other aortic valve replacement techniques.
In this series, two different techniques of Ross
procedure were employed. These included free standing
total root replacement and modified total root
replacement using Dacron interposition graft to stabilise
the autograft. The competency of autograft is enhanced
by complete root replacement as it maintains the
geometry of graft as well as remove all abnormal aortic
root parts. Prior literature has indicated higher rates of
aortic root dilatation and aortic regurgitation with
free standing root replacement without autograft
stabilisation.5 Although in this series, the outcome of
both techniques inclusive of mortality, neo-aorta
deterioration, and RVOT conduit failure requiring re-
operation were similar. However, it is difficult to compare
these techniques in a short case series. These results
necessitate the need to assess the results of various
Ross procedure practices in larger studies to provide
evidence for optimal technique to be implemented in this
population.
Another aspect to focus is the use of types of conduits
for right ventricular outflow tract reconstruction. RVOT is
considered to be the 'weak link' of Ross procedure
contributing to majority of re-operations. The well-
established transcatheter techniques enable the patients
to have longer freedom from re-operation now. Use of
Contegra, a gluteraldehyde-preserved heterologous
bovine internal jugular vein with a trileaflet venous valve,
provides the benefit of easy suturing without need of
proximal or distal extension and large availability of
various sizes (12 to 22 millimeters internal diameter).8
Long term durability of bovine jugular vein graft is
reported in a prior study with freedom from re-
intervention upto 90% at seven years.9 Another
technique utilised was manually constructed composite
valved conduit involving the use of PTFE membrane for
constructing RVOT patch within bovine pericardial tube.
The major benefit of PTFE membrane is its functionality
for longer periods by evading tissue ingrowth leading to
rates of freedom from re-operation ranging between
96% at one year, 89% at five years, and 82% at 10
years.10
CONCLUSION
The various techniques of Ross procedure utilising
pulmonary autograft carry freedom from risks of
anticoagulation, mortality, and RVOT conduit failure. All
these benefits merit the evaluation of these technical
varieties in larger studies assessing more practices with
longer follow-up time duration to devise optimal strategy
in younger adults. 
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